Codexis Inc

CDXSNASDAQ · USD
1.09USD+0.03 (+2.83%)
427

Codexis Inc (CDXS) Covered Calls

Codexis Inc trades in the Biotechnology industry with an IV Rank of 71.03%, high versus the past year. CDXS's highest covered call setup is the $2.00 strike expiring Jun 17, 2027, sorted by theoretical annualized return. It's 72.41% out of the money with 216 days to expiration, a 85.34% return until expiration, and a 144.22% theoretical annualized return. Across the setups shown, annualized returns run from 93.23% to 144.22% at strikes between $1.50 and $2.00, with 216 to 216 days to expiration, as of Nov 13, 2026.

Read more

Running CDXS covered calls helps you generate income from Codexis Inc shares you already own, turning a long stock position into a yield producing asset. A covered call means holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike. Use our scanner to find the best CDXS covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call pairs limited risk with a clear income profile. If CDXS stays below the strike at expiration, you keep the premium and the shares. If it rises above, you deliver the stock at the strike and still pocket the premium. Selling CDXS covered calls works best when implied volatility is elevated, since richer premiums improve the risk reward. Key inputs include strike selection relative to delta, days to expiration, annualized return, and probability of assignment, all of which determine whether a given CDXS covered call is worth writing.

Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes.

2027-06-172162.0072.410.150.9599.0085.34144.22-12.93+0.6900.80
2027-06-172161.5029.310.300.6064.0055.1793.23-25.86+0.6600.30

As of Nov 13, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV Rank71.03% High
  • Market cap (M$)116
  • 52 weeks high-64.43%
  • 52 weeks low17.78%
  • Analyst recommendationStrong Buy
    1.50
  • Target price$6.14
    463.30% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-11-12
  • P/E—
  • Future P/E—
  • EPS (ttm)-0.20
  • EPS growth next 5 years32.32%

As of Nov 16, 2026